Prospective assay for SARS-CoV-2 antibody detection indirectly by immunofluorescence: SARS-CoV2 IIF method
Sample preparation, serum separation by centrifugation
- 100 µl of serum for standard SARS-CoV2 ELISA is used according to the instructions for
use.
- 100 µl of serum indirect immunofluorescent (IIF) method is used, the samples thus
prepared analysis is performed under an automated microscope
Diagnostic Test: Immunfluorescence
Serum indirect immunofluorescent (IIF) method is used, analysis is performed under an automated microscope.
Inclusion Criteria:
- Person over 18 years of age
- Signing a package leaflet and a informal consent
- In the case of a positive group, confirmed by SARS-CoV2 qPCR Patient with COVID-19 or
recovered individual.
- In case of negative group by SARS-CoV2 qPCR test 2 negative in COVID-19 suffering
individual
Exclusion Criteria:
- Refuses to sign the consent form
University of Szeged, Albert Szent-Györgyi Health Center
Szeged, Hungary
Investigator: Katalin Burián, MD
Contact: +36 62 544 000
Katalin Burián, MD
+36 62 544 000
burian.katalin@med.u-szeged.hu
Dávid Pintér, Pharm. D.
Katalin Burián, MD, Principal Investigator
University of Szeged, Institute of Clinical Microbilogy